Showing results (101-110 of 108) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Cancers|January 10, 2026
15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter StudyBinbin Lai, Chen Mei, Xiao Yan, et al.British Journal of Haematology|June 11, 2025
EASIX score predicts non-relapse mortality and severe infection in elderly patients undergoing allo-HSCTLizhen Liu, Shipei Xiang, Junjie Cao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd StudyLi Zhang, Li Meng, Bingcheng Liu, et al.Frontiers in Oncology|July 14, 2022
A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 MutationLiya Ma, Bin Liang, Huixian Hu, et al.Bone Marrow Transplantation|December 3, 2024
Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?Bingqian Jiang, Tingting Yang, Yanmin Zhao, et al.American Journal of Hematology|May 26, 2026
Characteristics and Prognostic Implications in Newly Diagnosed KMT2Ar AML: A Multicenter Study of the ECLA GroupJiajia Pan, Chunmei Fu, Qing Ling, et al.British Journal of Haematology|July 12, 2023
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trialMixue Xie, Ying Lu, Guifang Ouyang, et al.Signal Transduction and Targeted Therapy|July 5, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trialFei Li, Keshu Zhou, Wei Xu, et al.Pageof 11